Purdue Pharma and its Sackler family owners reached a $7.4 billion opioid settlement. The deal allows lawsuits against the Sacklers, who will pay $6.5 billion.

All 50 states as well as the District of Columbia and U.S. territories have approved a $7.4 billion settlement with Purdue Pharma, maker of Oxycontin, over the company's improper marketing of opioids.

Under the new terms, a significant amount of the settlement funds will be distributed in the first three years, with the Sacklers paying $1.5 billion and Purdue paying nearly $900 million in the ...

Purdue Pharma, Sacklers reach new $7.4 billion opioid settlement. All 50 states as well as the District of Columbia and U.S. territories have approved a $7.4 billion settlement with Purdue Pharma ...

Purdue Pharma and its Sackler family owners have reached a new $7.4 billion settlement to resolve thousands of lawsuits alleging that the pain medication OxyContin caused a widespread opioid ...

Under the outlines of the deal, members of the Sackler family who currently own Purdue Pharma are expected to contribute roughly $6.5 billion. According to the company, a major change from past ...